Kevin Koch

Kevin Koch was the founder of Array BioPharma, Inc., founded in 1998, where the title held was President & Chief Scientific Officer from 2012 to 2013.
Current jobs include President, Chief Executive Officer & Director at Edgewise Therapeutics, Inc. since 2020; Director at Encycle Therapeutics, Inc.; Director at Neurogastrx, Inc. since 2018; Director at Skyhawk Therapeutics, Inc.; and Venture Partner at OrbiMed Advisors Private Equity since 2016.
Former jobs include Associate Director-Medicinal Chemistry at Amgen, Inc. from 1995 to 1998; Director at Inflammation Research Association, Inc. from 1998 to 2003; Director at Ataxion, Inc.; Independent Director at Viridian Therapeutics, Inc. from 2017 to 2020; Director at Terremoto Biosciences, Inc. from 2021 to 2023; Senior Vice President-Drug Discovery at Biogen, Inc. from 2013 to 2015; and Senior Research Investigator at Pfizer Inc. from 1988 to 1995.
Education includes a doctorate from Rochester Christian University and an undergraduate degree from Stony Brook University.